Optimizing Early Enteral Nutrition in Severe Stroke

NCT02982668 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2021-11-04

No results posted yet for this study

Summary

The purpose of this academic lead study is to explore the ideal nutritional support strategy for patient with acute severe stroke.

Conditions

Interventions

OTHER

Initial enteral feeding

DRUG

metoclopramide or mosapride

gastrointestinal (GI) motility improving

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER
  • Xi'an Central Hospital

    collaborator OTHER
  • Xi'an Gaoxin Hospital

    collaborator OTHER
  • Yan'an University Affiliated Hospital

    collaborator OTHER
  • 940 Hospital of the People's Liberation Army Joint Logistic Support Force

    collaborator OTHER
  • Xi'an No.3 Hospital

    collaborator OTHER_GOV
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Yulin No.1 Hospital

    collaborator UNKNOWN
  • First People's Hospital of Xianyang

    collaborator OTHER
  • Tongchuan Mining Hospital

    collaborator UNKNOWN
  • The PLA General Hospital of Xinjiang

    collaborator UNKNOWN
  • Tongchuan People's Hospital

    collaborator UNKNOWN
  • Yulin No.2 Hospital

    collaborator OTHER
  • Ankang Central Hospital

    collaborator OTHER
  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang, PhD · Department of Neurology, Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982668 on ClinicalTrials.gov